Unknown

Dataset Information

0

Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development.


ABSTRACT: Biofilm formation by pathogenic bacteria is an important virulence factor in the development of numerous chronic infections, thereby causing a severe health burden. Many of these infections cannot be resolved, as bacteria in biofilms are resistant to the host's immune defenses and antibiotic therapy. An urgent need for new strategies to treat biofilm-based infections is critically needed. Cyclic di-GMP (c-di-GMP) is a widely conserved second-messenger signal essential for biofilm formation. The absence of this signalling system in higher eukaryotes makes it an attractive target for the development of new anti-biofilm agents. In this study, the results of an in silico pharmacophore-based screen to identify small-molecule inhibitors of diguanylate cyclase (DGC) enzymes that synthesize c-di-GMP are described. Four small molecules, LP 3134, LP 3145, LP 4010 and LP 1062 that antagonize these enzymes and inhibit biofilm formation by Pseudomonas aeruginosa and Acinetobacter baumannii in a continuous-flow system are reported. All four molecules dispersed P. aeruginosa biofilms and inhibited biofilm development on urinary catheters. One molecule dispersed A. baumannii biofilms. Two molecules displayed no toxic effects on eukaryotic cells. These molecules represent the first compounds identified from an in silico screen that are able to inhibit DGC activity to prevent biofilm formation.

SUBMITTER: Sambanthamoorthy K 

PROVIDER: S-EPMC4120261 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development.

Sambanthamoorthy Karthik K   Luo Chunyuan C   Pattabiraman Nagarajan N   Feng Xiarong X   Koestler Benjamin B   Waters Christopher M CM   Palys Thomas J TJ  

Biofouling 20131011 1


Biofilm formation by pathogenic bacteria is an important virulence factor in the development of numerous chronic infections, thereby causing a severe health burden. Many of these infections cannot be resolved, as bacteria in biofilms are resistant to the host's immune defenses and antibiotic therapy. An urgent need for new strategies to treat biofilm-based infections is critically needed. Cyclic di-GMP (c-di-GMP) is a widely conserved second-messenger signal essential for biofilm formation. The  ...[more]

Similar Datasets

| S-EPMC6138535 | biostudies-literature
| S-EPMC3165641 | biostudies-literature
| S-EPMC3084805 | biostudies-literature
| S-EPMC8570270 | biostudies-literature
| S-EPMC7186502 | biostudies-literature
| S-EPMC7033309 | biostudies-literature
| S-EPMC2957078 | biostudies-literature
| S-EPMC5526357 | biostudies-literature
| S-EPMC2861480 | biostudies-literature
| S-EPMC10552763 | biostudies-literature